In8bio Inc Cash Flow-to-Debt Ratio
In8bio Inc cash flow-to-debt ratio. In8bio Inc (INAB) has a Cash Flow-to-Debt Ratio of -1.11x as of June 2026, meaning its operating cash flow of $-3.75 Million could theoretically repay -1% of its total liabilities ($3.38 Million) in one year. See In8bio Inc (INAB) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of In8bio Inc (2018–2025)
Cash flow-to-debt ratio of In8bio Inc from 2018 to 2025. Historical debt coverage capacity for In8bio Inc across 8 annual periods. Also explore INAB net assets growth trend to track the company's year-over-year net asset growth rate.
In8bio Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
In8bio Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for In8bio Inc. For the full cash flow conversion analysis, see In8bio Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.69x | $-12.71 Million | $4.72 Million | ▲ +27.9% |
| 2024 | -3.73x | $-24.15 Million | $6.47 Million | ▼ -40.4% |
| 2023 | -2.66x | $-23.34 Million | $8.77 Million | ▼ -13.7% |
| 2022 | -2.34x | $-24.12 Million | $10.31 Million | ▲ +30.0% |
| 2021 | -3.34x | $-13.51 Million | $4.04 Million | ▼ -21.4% |
| 2020 | -2.76x | $-7.13 Million | $2.59 Million | ▲ +15.3% |
| 2019 | -3.25x | $-4.80 Million | $1.48 Million | ▼ -46.6% |
| 2018 | -2.22x | $-2.77 Million | $1.25 Million | — |